RB family members as predictive and prognostic factors in human cancer

被引:0
|
作者
G Scambia
S Lovergine
V Masciullo
机构
[1] Catholic University,Division of Gynecologic Oncology
[2] Sbarro Institute for Cancer Research,undefined
[3] College of Science and Technology,undefined
[4] Temple University,undefined
来源
Oncogene | 2006年 / 25卷
关键词
pRb; pRb2; p130; prognostic factor; predictive factor;
D O I
暂无
中图分类号
学科分类号
摘要
The retinoblastoma family members – pRb, pRb2/p130 and p107 – are tumor suppressor genes involved in controlling four major cellular processes: growth arrest, apoptosis, differentiation and angiogenesis. Molecular genetic studies have identified abnormalities of these tumor suppressor genes in a large proportion of human cancers. These genetic alterations have emerged as significant factors in the pathogenesis and progression of many types of tumors and are therefore likely to provide relevant information to assess risk in cancer patients. There is a pressing clinical need to identify prognostic and predictive factors for patients with cancer, because there is an undeniable importance in being able to determine which patients will have a favorable outcome without further therapy (prognostic factor) and which will need some additional treatment (predictive factor). This review examines the predictive and/or prognostic role of each retinoblastoma family member in human cancer.
引用
收藏
页码:5302 / 5308
页数:6
相关论文
共 50 条
  • [11] Fruquintinib in metastatic colorectal cancer: a multicenter real-world analysis on efficacy, safety, and predictive and prognostic factors
    Wang, Yi
    Xu, Jianfen
    Dong, Mingjun
    Liu, Kaitai
    Lu, Yi
    Chen, Ke
    Cao, Yuepeng
    Shi, Hang
    Bei, Yanping
    Li, Jianjiong
    Zhao, Jianpei
    Cao, Yisheng
    Lu, Ning
    Yang, Lu
    Liu, Haizhong
    Cai, Ping
    Li, Kai
    Yang, Tong
    He, Ning
    Dong, Jing
    Zhang, Chen
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (04) : 1519 - 1533
  • [12] Prognostic and treatment-predictive factors—is there a difference?
    J Adolfsson
    G Steineck
    Prostate Cancer and Prostatic Diseases, 2000, 3 : 265 - 268
  • [13] Predictive factors for anthracycline-based chemotherapy for human breast cancer
    Miyoshi, Yasuo
    Kurosumi, Masafumi
    Kurebayashi, Junichi
    Matsuura, Nariaki
    Takahashi, Masato
    Tokunaga, Eriko
    Egawa, Chiyomi
    Masuda, Norikazu
    Kono, Seishi
    Morimoto, Koji
    Kim, Seung Jin
    Okishiro, Masatsugu
    Yanagisawa, Tetsu
    Ueda, Satsuki
    Taguchi, Tetsuya
    Tamaki, Yasuhiro
    Noguchi, Shinzaburo
    BREAST CANCER, 2010, 17 (02) : 103 - 109
  • [14] Predictive factors for anthracycline-based chemotherapy for human breast cancer
    Yasuo Miyoshi
    Masafumi Kurosumi
    Junichi Kurebayashi
    Nariaki Matsuura
    Masato Takahashi
    Eriko Tokunaga
    Chiyomi Egawa
    Norikazu Masuda
    Seishi Kono
    Koji Morimoto
    Seung Jin Kim
    Masatsugu Okishiro
    Tetsu Yanagisawa
    Satsuki Ueda
    Tetsuya Taguchi
    Yasuhiro Tamaki
    Shinzaburo Noguchi
    Breast Cancer, 2010, 17 : 103 - 109
  • [15] Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens
    Amin, M
    Boccon-Gibod, L
    Egevad, L
    Epstein, JI
    Humphrey, PA
    Mikuz, G
    Newling, D
    Nilsson, S
    Sakr, W
    Srigley, JR
    Wheeler, TM
    Montironi, R
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2005, 39 : 20 - 33
  • [16] TP53 mutations and SNPs as prognostic and predictive factors in patients with breast cancer (Review)
    Huszno, Joanna
    Grzybowska, Ewa
    ONCOLOGY LETTERS, 2018, 16 (01) : 34 - 40
  • [17] Predictive and prognostic factors of septic shock of nosocomial origin
    JP Quenot
    A Pavon
    C Binquet
    F Kara
    O Martinet
    F Ganster
    JC Navellou
    V Castelain
    D Barraud
    J Cousson
    JF Poussel
    P Perez
    K Kuteifan
    A Noirot
    Critical Care, 16 (Suppl 1):
  • [18] Prognostic and predictive value of c-erbB-2 (HER-2/neu) gene amplification in human breast cancer
    Tsuda H.
    Breast Cancer, 2001, 8 (1) : 38 - 44
  • [19] Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population
    Kan Yonemori
    Umio Yamaguchi
    Masayuki Kaneko
    Hajime Uno
    Masahiro Takeuchi
    Masashi Ando
    Yasuhiro Fujiwara
    Ako Hosono
    Atsushi Makimoto
    Tadashi Hasegawa
    Ryouhei Yokoyama
    Fumihiko Nakatani
    Akira Kawai
    Yasuo Beppu
    Hirokazu Chuman
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 389 - 395
  • [20] Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer
    Doetzer, Katharina
    Schlueter, Friederike
    Koch, Franz Edler von
    Brambs, Christine E.
    Anthuber, Sabine
    Frangini, Sergio
    Czogalla, Bastian
    Burges, Alexander
    Werner, Jens
    Mahner, Sven
    Mayer, Barbara
    BIOMEDICINES, 2021, 9 (03) : 1 - 12